Skip to main content
Live · TradingView
Back to the NewsWire

Biospace

Published September 14, 2026 · Updated September 15, 2026

Definium moves toward FDA submission for LSD drug in anxiety after 'another clear win'

Read the full story at Biospace

Fifty-two patients received a 50-ug dose—a cohort that “was not designed or powered for statistical comparisons,” per Definium's press release .

Surfaced by 2 Google Alerts

  • Psychedelic press release
  • Psychedelic biotech